The latest price target for DaVita (NYSE:DVA) was reported by Barclays on October 31, 2024. The analyst firm set a price target for $164.00 expecting DVA to rise to within 12 months (a possible 0.83% upside). 13 analyst firms have reported ratings in the last year.

The latest analyst rating for DaVita (NYSE:DVA) was provided by Barclays, and DaVita maintained their equal-weight rating.

The last upgrade for DaVita Inc happened on August 7, 2023 when UBS raised their price target to $142. UBS previously had a neutral for DaVita Inc.

The last downgrade for DaVita Inc happened on October 31, 2022 when UBS changed their price target from $117 to $74 for DaVita Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DaVita, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DaVita was filed on October 31, 2024 so you should expect the next rating to be made available sometime around October 31, 2025.

While ratings are subjective and will change, the latest DaVita (DVA) rating was a maintained with a price target of $150.00 to $164.00. The current price DaVita (DVA) is trading at is $162.66, which is within the analyst’s predicted range.